Janney Montgomery Scott’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.2M	Buy	2,016,464 +728,632	+57%	+$6.98M	0.04%	412
2025 Q4	$15M	Buy	1,287,832 +74,812	+6%	+$728K	0.03%	458
2025 Q3	$12.2M	Buy	1,213,020 +621,595	+105%	+$8.92M	0.03%	523
2025 Q2	$10.3M	Buy	591,425 +142,756	+32%	+$2.06M	0.03%	552
2025 Q1	$5.64M	Buy	448,669 +421,511	+1,552%	+$5.07M	0.02%	731
2024 Q4	$287K	Sell	27,158 -2,000	-7%	-$28K	﹤0.01%	2338
2024 Q3	$423K	Buy	29,158 +4,672	+19%	+$55.6K	﹤0.01%	2079
2024 Q2	$208K	Hold	24,486	–	–	﹤0.01%	2431
2024 Q1	$250K	Buy	24,486 +881	+4%	+$6.57K	﹤0.01%	2445
2023 Q4	$129K	Sell	23,605 -467	-2%	-$2.05K	﹤0.01%	2529
2023 Q3	$91K	Sell	24,072 -15,897	-40%	-$104K	﹤0.01%	2485
2023 Q2	$268K	Sell	39,969 -10,274	-20%	-$68.6K	﹤0.01%	2298
2023 Q1	$327K	Sell	50,243 -3,471	-6%	-$26.7K	﹤0.01%	1998
2022 Q4	$458K	Sell	53,714 -28,319	-35%	-$184K	﹤0.01%	1835
2022 Q3	$433K	Sell	82,033 -6,425	-7%	-$31.7K	﹤0.01%	1791
2022 Q2	$379K	Buy	88,458 +3,892	+5%	+$13.6K	﹤0.01%	1766
2022 Q1	$297K	Sell	84,566 -165	-0.2%	-$718	﹤0.01%	1889
2021 Q4	$564K	Buy	84,731 +69,203	+446%	+$562K	﹤0.01%	1642
2021 Q3	$155K	Sell	15,528 -580	-4%	-$14.3K	﹤0.01%	2198
2021 Q2	$498K	Buy	16,108 +248	+2%	+$7.95K	﹤0.01%	1638
2021 Q1	$692K	Buy	15,860 +4,903	+45%	+$232K	﹤0.01%	1388
2020 Q4	$508K	Buy	+10,957	New	+$366K	﹤0.01%	1561